Evaluate PBYI stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in PBYI? | Glauxie AI

Q: What are the risks of investing in PBYI?

Puma Biotechnology, Inc. (PBYI) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Alan H. Auerbach. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug... Employees: 179.

Q: How much debt does PBYI have?

Review PBYI total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is PBYI a good long-term investment?

Evaluate PBYI as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in PBYI?

🦉

Puma Biotechnology, Inc. (PBYI)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAlan H. Auerbach

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage...

Key Executives

Name	Title
Alan H. Auerbach	Founder, Chairman, President, Chief Executive Officer & Secretary
Douglas Hunt FRAPS	Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
Heather Blaber	Senior Vice President of Marketing
Mariann Ohanesian	Senior Director of Investor Relations
Maximo F. Nougues	Chief Financial Officer & Principal Accounting Officer
Roger L. Storms	Senior Vice President of Sales

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

PBYI Profile Financials

Is PBYI stock safe? How much debt does PBYI have? Is PBYI a good long-term investment?